Scope Fluidics S.A.

Warsaw Stock Exchange SCP.WA

Scope Fluidics S.A. Gross Profit Margin for the year ending December 31, 2023: -265.89%

Scope Fluidics S.A. Gross Profit Margin is -265.89% for the year ending December 31, 2023, a -129.53% change year over year. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.
  • Scope Fluidics S.A. Gross Profit Margin for the year ending December 31, 2022 was -115.84%.
Key data
Date Gross Profit Margin Operating Income Margin EBT Margin Net Income Margin
Market news
Warsaw Stock Exchange: SCP.WA

Scope Fluidics S.A.

CEO Mr. Piotr Garstecki
IPO Date Aug. 1, 2017
Location Poland
Headquarters 9th floor
Employees 40
Sector Health Care
Industries
Biotechnology Pharmaceuticals
Description

Scope Fluidics S.A., a biotechnology company, engages in the designing and developing projects based on microfluidic technologies in medical diagnostics and healthcare. It offers BacterOMIC, an antibiotic susceptibility testing. The company was founded in 2010 and is based in Warsaw, Poland.

Similar companies

COG.WA

Cognor Holding S.A.

USD 1.64

0.89%

BMC.WA

Bumech S.A.

USD 2.85

2.48%

StockViz Staff

January 15, 2025

Any question? Send us an email